首页 > 最新文献

Qatar Medical Journal最新文献

英文 中文
Comparison of four diagnostic techniques for Cryptosporidium detection in Qatar. 卡塔尔隐孢子虫四种诊断技术的比较。
Q3 Medicine Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.78
Sallama Sabooni, Husam Salah, Rajvir Singh, Khloud Al-Qadi, Saad J Taj-Aldeen, Emad Ibrahim

Background: Cryptosporidium is a common pathogenic parasite known to cause diarrhea in humans and animals, particularly in young children living in poor conditions. Although diarrheal disease is usually mild in immunocompetent individuals, it may progress into a life-threatening complication among the immunocompromised. Due to insensitive conventional diagnostic methods, the identification of Cryptosporidium can be inaccurate and challenging. The present study aimed to investigate the prevalence of cryptosporidiosis infection in Qatar by comparing four different diagnostic methods for detecting Cryptosporidium in human stool samples.

Methods: From January 2018 to December 2019, stool samples from patients with various gastrointestinal symptoms were collected at the microbiology laboratory at Hamad General Hospital in Qatar for parasitic detection. The stool samples were tested using four diagnostic methods: routine microscopy, immunochromatography (ICT), multiplex polymerase chain reaction (PCR), and modified Kinyoun's acid-fast stain (MKS).

Results: In the evaluation of the four different detection methods, 36 (18%) out of 205 stool samples tested positive for Cryptosporidium, with detection rates of 18%, 15%, 7%, and 6% using PCR, ICT, MKS, and routine microscopy, respectively.

Conclusion: The superior sensitivity of PCR and ICT supports their integration into routine diagnostics to improve the detection and public health surveillance of cryptosporidiosis in Qatar.

背景:隐孢子虫是一种常见的致病性寄生虫,已知可引起人类和动物腹泻,特别是生活条件恶劣的幼儿。虽然腹泻病在免疫正常的个体中通常是轻微的,但在免疫功能低下的个体中可能会发展成危及生命的并发症。由于传统的诊断方法不敏感,隐孢子虫的鉴定可能是不准确和具有挑战性的。本研究旨在通过比较四种不同的检测人类粪便样本隐孢子虫的诊断方法,调查卡塔尔隐孢子虫病感染的流行情况。方法:2018年1月至2019年12月,在卡塔尔哈马德总医院微生物实验室采集各种胃肠道症状患者的粪便标本,进行寄生虫检测。采用常规镜检、免疫层析(ICT)、多重聚合酶链反应(PCR)和改良的金氏抗酸染色(MKS)四种诊断方法对粪便标本进行检测。结果:在4种不同检测方法的评价中,205份粪便标本中隐孢子虫阳性36例(18%),PCR、ICT、MKS和常规镜检检出率分别为18%、15%、7%和6%。结论:PCR和ICT具有较高的灵敏度,可用于卡塔尔隐孢子虫病的常规诊断,提高卡塔尔隐孢子虫病的检测和公共卫生监测水平。
{"title":"Comparison of four diagnostic techniques for <i>Cryptosporidium</i> detection in Qatar.","authors":"Sallama Sabooni, Husam Salah, Rajvir Singh, Khloud Al-Qadi, Saad J Taj-Aldeen, Emad Ibrahim","doi":"10.5339/qmj.2025.78","DOIUrl":"10.5339/qmj.2025.78","url":null,"abstract":"<p><strong>Background: </strong><i>Cryptosporidium</i> is a common pathogenic parasite known to cause diarrhea in humans and animals, particularly in young children living in poor conditions. Although diarrheal disease is usually mild in immunocompetent individuals, it may progress into a life-threatening complication among the immunocompromised. Due to insensitive conventional diagnostic methods, the identification of <i>Cryptosporidium</i> can be inaccurate and challenging. The present study aimed to investigate the prevalence of cryptosporidiosis infection in Qatar by comparing four different diagnostic methods for detecting <i>Cryptosporidium</i> in human stool samples.</p><p><strong>Methods: </strong>From January 2018 to December 2019, stool samples from patients with various gastrointestinal symptoms were collected at the microbiology laboratory at Hamad General Hospital in Qatar for parasitic detection. The stool samples were tested using four diagnostic methods: routine microscopy, immunochromatography (ICT), multiplex polymerase chain reaction (PCR), and modified Kinyoun's acid-fast stain (MKS).</p><p><strong>Results: </strong>In the evaluation of the four different detection methods, 36 (18%) out of 205 stool samples tested positive for <i>Cryptosporidium</i>, with detection rates of 18%, 15%, 7%, and 6% using PCR, ICT, MKS, and routine microscopy, respectively.</p><p><strong>Conclusion: </strong>The superior sensitivity of PCR and ICT supports their integration into routine diagnostics to improve the detection and public health surveillance of cryptosporidiosis in Qatar.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 3","pages":"78"},"PeriodicalIF":0.0,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144977856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of fixed-dose intravenous dexmedetomidine on emergence delirium after general anesthesia for a surgery in pediatric patients - A randomized controlled trial. 固定剂量静脉注射右美托咪定对小儿手术全麻后出现性谵妄的影响——一项随机对照试验。
Q3 Medicine Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.95
Anwar Ul Huda, Mohammad Yasir, Mohammad Zulqarnain Mughal, Asim Arif

Background: Emergence delirium (ED) in pediatric patients can result in bodily harms, maladaptive changes, and longer post-anesthesia care unit (PACU) stays. The incidence of ED varies in pediatric patients depending on various factors such as age, type of anesthesia, type of surgery, pain, and the choice of diagnostic tools. Various pharmacological and non-pharmacological methods have been used to reduce its incidence postoperatively. This study aims to investigate the role of a fixed dose of intravenous dexmedetomidine in preventing ED in pediatric patients.

Methods: Approval from the institutional ethical committee was obtained for this randomized controlled trial. Inclusion criteria included pediatric patients aged between 2 and 12 years, with ASA scores ranging from 1 to 3, who were scheduled to undergo general anesthesia for a surgical procedure. The intervention group received 20 ml of 0.2 mcg/kg dexmedetomidine intravenously over a period of 20 minutes before the end of the operation. In contrast, the control group received 20 ml of 0.9% saline. The primary outcome measure of this study was the incidence of ED in the PACU. All data collected during the study were entered and analyzed using the SPSS 22.0 statistical package program.

Results: A total of 66 patients were included in the study. All baseline characteristics of both groups were similar. The incidence of ED in the control group was 42% (14/33), whereas it was 15% (5/33) in the dexmedetomidine group (p = 0.014).

Conclusion: The use of 0.2 mcg/kg intravenous dexmedetomidine reduces the incidence of ED in patients undergoing general anesthesia with sevoflurane.

背景:儿科患者突发性谵妄(ED)可导致身体伤害、适应不良改变和麻醉后护理病房(PACU)住院时间延长。儿科患者ED的发病率因年龄、麻醉类型、手术类型、疼痛和诊断工具的选择等因素而异。各种药物和非药物方法已被用于减少其术后发生率。本研究旨在探讨固定剂量静脉注射右美托咪定在预防儿科患者ED中的作用。方法:该随机对照试验获得了机构伦理委员会的批准。纳入标准包括年龄在2 - 12岁之间,ASA评分在1 - 3分之间的儿科患者,他们计划接受外科手术的全身麻醉。干预组在手术结束前20分钟静脉滴注0.2 mcg/kg右美托咪定20 ml。对照组给予0.9%生理盐水20 ml。本研究的主要结局指标是PACU中ED的发生率。在研究过程中收集的所有数据均使用SPSS 22.0统计软件包程序进行输入和分析。结果:共纳入66例患者。两组的所有基线特征相似。对照组ED发生率为42%(14/33),右美托咪定组ED发生率为15% (5/33)(p = 0.014)。结论:静脉注射0.2 mcg/kg右美托咪定可降低七氟醚全身麻醉患者ED的发生率。
{"title":"Effect of fixed-dose intravenous dexmedetomidine on emergence delirium after general anesthesia for a surgery in pediatric patients - A randomized controlled trial.","authors":"Anwar Ul Huda, Mohammad Yasir, Mohammad Zulqarnain Mughal, Asim Arif","doi":"10.5339/qmj.2025.95","DOIUrl":"10.5339/qmj.2025.95","url":null,"abstract":"<p><strong>Background: </strong>Emergence delirium (ED) in pediatric patients can result in bodily harms, maladaptive changes, and longer post-anesthesia care unit (PACU) stays. The incidence of ED varies in pediatric patients depending on various factors such as age, type of anesthesia, type of surgery, pain, and the choice of diagnostic tools. Various pharmacological and non-pharmacological methods have been used to reduce its incidence postoperatively. This study aims to investigate the role of a fixed dose of intravenous dexmedetomidine in preventing ED in pediatric patients.</p><p><strong>Methods: </strong>Approval from the institutional ethical committee was obtained for this randomized controlled trial. Inclusion criteria included pediatric patients aged between 2 and 12 years, with ASA scores ranging from 1 to 3, who were scheduled to undergo general anesthesia for a surgical procedure. The intervention group received 20 ml of 0.2 mcg/kg dexmedetomidine intravenously over a period of 20 minutes before the end of the operation. In contrast, the control group received 20 ml of 0.9% saline. The primary outcome measure of this study was the incidence of ED in the PACU. All data collected during the study were entered and analyzed using the SPSS 22.0 statistical package program.</p><p><strong>Results: </strong>A total of 66 patients were included in the study. All baseline characteristics of both groups were similar. The incidence of ED in the control group was 42% (14/33), whereas it was 15% (5/33) in the dexmedetomidine group (<i>p</i> = 0.014).</p><p><strong>Conclusion: </strong>The use of 0.2 mcg/kg intravenous dexmedetomidine reduces the incidence of ED in patients undergoing general anesthesia with sevoflurane.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 3","pages":"95"},"PeriodicalIF":0.0,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144977930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of post-corrosive gastric outlet obstruction: Outcome assessment in adults and pediatric patients in resource-limited settings. 腐蚀后胃出口梗阻的外科治疗:资源有限的成人和儿童患者的结局评估。
Q3 Medicine Pub Date : 2025-08-12 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.74
Anas Mohammed Shuwail, Ali Lotf Al-Amry, Yasser Abdurabo Obadiel, Mohammed Mohammed Alsurmi, Afaf Mohammed Al-Dhubaibi, Jalal Mohammed Al-Hubaishi, Haitham Mohammed Jowah

Objective: This study aims to evaluate the outcomes of surgical treatment in adult and pediatric patients with post-corrosive gastric outlet obstruction (GOO) in Yemen.

Patients and methods: A prospective observational study was conducted at Al-Thawra Modern General Hospital (TMGH), from January 1, 2019 to January 31, 2023. The study involved 77 patients, comprising both adults and children, who were admitted for surgical treatment of post-corrosive GOO. Data were collected from medical records, patient interviews, and follow-up visits.

Results: Among the 77 patients, 77% (n = 59) were pediatric patients and 23% (n = 18) were adults. The mean age of the cohort was 10.6 years, with an average age of 4.12 years for pediatric patients and 30.8 years for adults. The primary cause of post-corrosive GOO was the accidental ingestion of acidic substances, accounting for 97% of cases. Common symptoms at presentation included vomiting, early satiety, and weight loss. Definitive surgery was performed in one stage in 95% of patients, with Heineke-Mikulicz pyloroplasty being the most common procedure (82%) in pediatric cases, whereas gastrojejunostomy was mainly used in adults (67%). Postoperative complications occurred in 22% of patients, with vomiting, wound infection, and aspiration pneumonia being the most common. Anastomotic restriction was observed in two pediatric patients who required reoperation. The overall mortality rate was 1.3%, with one pediatric patient having succumbed. Notably, improvements in GOO symptoms were observed in 96% of patients. Pediatric patients had a longer median hospital stay (6.5 days) than adult patients (6 days).

Conclusion: Corrosive injuries, particularly in the pediatric population, pose a significant issue in Yemen due to the unsafe storage of sulfuric acid. It is recommended to conduct early surgical interventions within 4 weeks after ingestion to prevent weight loss and to reduce prolonged hospitalization. Further research and interventions are needed to prevent such injuries, improve public awareness, and regulate the sale and storage of corrosive substances.

目的:本研究旨在评估也门成人和儿童腐蚀性胃出口梗阻(GOO)患者的手术治疗效果。患者和方法:于2019年1月1日至2023年1月31日在Al-Thawra现代总医院(TMGH)进行了一项前瞻性观察性研究。该研究涉及77例患者,包括成人和儿童,他们接受手术治疗后腐蚀粘稠。数据收集自医疗记录、患者访谈和随访。结果:77例患者中,77% (n = 59)为儿科患者,23% (n = 18)为成人患者。该队列的平均年龄为10.6岁,其中儿科患者的平均年龄为4.12岁,成人的平均年龄为30.8岁。腐蚀后粘稠的主要原因是误食酸性物质,占97%。常见症状包括呕吐、早期饱腹感和体重减轻。95%的患者一期完成最终手术,在儿童病例中,Heineke-Mikulicz幽门成形术是最常见的手术(82%),而胃空肠吻合术主要用于成人(67%)。22%的患者出现术后并发症,呕吐、伤口感染和吸入性肺炎最为常见。吻合口受限2例患儿需再次手术。总死亡率为1.3%,1名儿科患者死亡。值得注意的是,96%的患者观察到粘稠症状的改善。儿科患者的中位住院时间(6.5天)比成人患者(6天)更长。结论:腐蚀性伤害,特别是在儿科人群中,由于不安全的硫酸储存,在也门构成了一个重大问题。建议在摄入后4周内进行早期手术干预,防止体重下降,减少住院时间延长。需要进一步的研究和干预措施,以防止这种伤害,提高公众意识,并规范腐蚀性物质的销售和储存。
{"title":"Surgical management of post-corrosive gastric outlet obstruction: Outcome assessment in adults and pediatric patients in resource-limited settings.","authors":"Anas Mohammed Shuwail, Ali Lotf Al-Amry, Yasser Abdurabo Obadiel, Mohammed Mohammed Alsurmi, Afaf Mohammed Al-Dhubaibi, Jalal Mohammed Al-Hubaishi, Haitham Mohammed Jowah","doi":"10.5339/qmj.2025.74","DOIUrl":"10.5339/qmj.2025.74","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the outcomes of surgical treatment in adult and pediatric patients with post-corrosive gastric outlet obstruction (GOO) in Yemen.</p><p><strong>Patients and methods: </strong>A prospective observational study was conducted at Al-Thawra Modern General Hospital (TMGH), from January 1, 2019 to January 31, 2023. The study involved 77 patients, comprising both adults and children, who were admitted for surgical treatment of post-corrosive GOO. Data were collected from medical records, patient interviews, and follow-up visits.</p><p><strong>Results: </strong>Among the 77 patients, 77% (<i>n</i> = 59) were pediatric patients and 23% (<i>n</i> = 18) were adults. The mean age of the cohort was 10.6 years, with an average age of 4.12 years for pediatric patients and 30.8 years for adults. The primary cause of post-corrosive GOO was the accidental ingestion of acidic substances, accounting for 97% of cases. Common symptoms at presentation included vomiting, early satiety, and weight loss. Definitive surgery was performed in one stage in 95% of patients, with Heineke-Mikulicz pyloroplasty being the most common procedure (82%) in pediatric cases, whereas gastrojejunostomy was mainly used in adults (67%). Postoperative complications occurred in 22% of patients, with vomiting, wound infection, and aspiration pneumonia being the most common. Anastomotic restriction was observed in two pediatric patients who required reoperation. The overall mortality rate was 1.3%, with one pediatric patient having succumbed. Notably, improvements in GOO symptoms were observed in 96% of patients. Pediatric patients had a longer median hospital stay (6.5 days) than adult patients (6 days).</p><p><strong>Conclusion: </strong>Corrosive injuries, particularly in the pediatric population, pose a significant issue in Yemen due to the unsafe storage of sulfuric acid. It is recommended to conduct early surgical interventions within 4 weeks after ingestion to prevent weight loss and to reduce prolonged hospitalization. Further research and interventions are needed to prevent such injuries, improve public awareness, and regulate the sale and storage of corrosive substances.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 3","pages":"74"},"PeriodicalIF":0.0,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between thyroid hormone levels and hematological indices among women with thyroid disorders. 甲状腺疾病妇女甲状腺激素水平与血液学指标的关系
Q3 Medicine Pub Date : 2025-08-12 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.73
Sura O Al-Dewachi, Anmar B Al-Dewachi, Raad Yahya Alhamdani

Background: Dysfunctions in thyroid hormones induce various effects on hematopoiesis such as anemia, changes in red blood cells (RBC) and platelet counts, as well as changes in hematological indices. The aim of the present study was to assess the association between thyroid hormone levels and hematological indices among women with thyroid dysfunction who were attending an outpatient clinic in Mosul, Iraq.

Methods: This case-control study was conducted at Al-Wafa Specialist Centre for Diabetes and Endocrine Diseases from April to July 2024. A total of 300 women participated in this study (100 with hypothyroidism, 100 with hyperthyroidism, and 100 with normal thyroid function serving as controls). The hematological indices of the three groups were analyzed and compared. Blood indices were analyzed using the Mythic-18 hematology analyzer. Ethical approval was obtained before data collection, and written consent was obtained from all participants.

Results: All RBC indices [hemoglobin (Hb), RBC count, hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC)] were significantly lower in patients with hypothyroidism compared to those in the control group (p ≤ 0.05), except for red blood cell distribution width (RDW), which was significantly higher in patients with hypothyroidism (p = 0.000).White blood cell count was significantly lower in patient with hypothyroidism compared to those in the control group (p = 0.000). In contrast, no statistically significant differences were observed in any blood indices in patients with hyperthyroidism compared to the control group. A statistically significant negative correlation was identified between thyroid-stimulating hormone and Hb, RBC count, HCT, MCV, MCH, alongside a statistically significant positive correlation with RDW.

Conclusion: The dysfunction of thyroid hormones has an impact on blood indices. Anemia is frequently observed in patients with thyroid dysfunction, especially in cases of hypothyroidism. Variations in blood indices may indicate underlying thyroid disorders. Therefore, it is imperative not to disregard the assessment of thyroid hormones in cases of unexplained anemia or unaccounted changes in blood indices.

背景:甲状腺激素的功能障碍会对造血产生各种影响,如贫血、红细胞和血小板计数的变化以及血液学指标的变化。本研究的目的是评估在伊拉克摩苏尔一家门诊就诊的甲状腺功能障碍妇女甲状腺激素水平和血液学指标之间的关系。方法:本病例对照研究于2024年4 - 7月在Al-Wafa糖尿病和内分泌疾病专科中心进行。共有300名女性参与了这项研究(100名甲状腺功能减退患者,100名甲状腺功能亢进患者,100名甲状腺功能正常的女性作为对照)。对三组患者血液学指标进行分析比较。采用Mythic-18血液学分析仪分析血液指标。收集数据前获得伦理批准,并获得所有参与者的书面同意。结果:除红细胞分布宽度(RDW)显著高于甲状腺功能减退患者外,甲状腺功能减退患者各项红细胞指标[血红蛋白(Hb)、红细胞计数、红细胞压积(HCT)、平均红细胞体积(MCV)、平均红细胞血红蛋白(MCH)、平均红细胞血红蛋白浓度(MCHC)]均显著低于对照组(p≤0.05)。甲状腺功能减退患者白细胞计数明显低于对照组(p = 0.000)。相比之下,甲状腺机能亢进患者的任何血液指标与对照组相比均无统计学差异。促甲状腺激素与Hb、RBC计数、HCT、MCV、MCH呈显著负相关,与RDW呈显著正相关。结论:甲状腺激素功能障碍对血液指标有影响。贫血常见于甲状腺功能障碍患者,尤其是甲状腺功能减退患者。血液指标的变化可能表明潜在的甲状腺疾病。因此,在不明原因的贫血或不明原因的血液指标变化的情况下,不可忽视甲状腺激素的评估。
{"title":"Association between thyroid hormone levels and hematological indices among women with thyroid disorders.","authors":"Sura O Al-Dewachi, Anmar B Al-Dewachi, Raad Yahya Alhamdani","doi":"10.5339/qmj.2025.73","DOIUrl":"10.5339/qmj.2025.73","url":null,"abstract":"<p><strong>Background: </strong>Dysfunctions in thyroid hormones induce various effects on hematopoiesis such as anemia, changes in red blood cells (RBC) and platelet counts, as well as changes in hematological indices. The aim of the present study was to assess the association between thyroid hormone levels and hematological indices among women with thyroid dysfunction who were attending an outpatient clinic in Mosul, Iraq.</p><p><strong>Methods: </strong>This case-control study was conducted at Al-Wafa Specialist Centre for Diabetes and Endocrine Diseases from April to July 2024. A total of 300 women participated in this study (100 with hypothyroidism, 100 with hyperthyroidism, and 100 with normal thyroid function serving as controls). The hematological indices of the three groups were analyzed and compared. Blood indices were analyzed using the Mythic-18 hematology analyzer. Ethical approval was obtained before data collection, and written consent was obtained from all participants.</p><p><strong>Results: </strong>All RBC indices [hemoglobin (Hb), RBC count, hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC)] were significantly lower in patients with hypothyroidism compared to those in the control group (<i>p</i> ≤ 0.05), except for red blood cell distribution width (RDW), which was significantly higher in patients with hypothyroidism (<i>p</i> = 0.000).White blood cell count was significantly lower in patient with hypothyroidism compared to those in the control group (<i>p</i> = 0.000). In contrast, no statistically significant differences were observed in any blood indices in patients with hyperthyroidism compared to the control group. A statistically significant negative correlation was identified between thyroid-stimulating hormone and Hb, RBC count, HCT, MCV, MCH, alongside a statistically significant positive correlation with RDW.</p><p><strong>Conclusion: </strong>The dysfunction of thyroid hormones has an impact on blood indices. Anemia is frequently observed in patients with thyroid dysfunction, especially in cases of hypothyroidism. Variations in blood indices may indicate underlying thyroid disorders. Therefore, it is imperative not to disregard the assessment of thyroid hormones in cases of unexplained anemia or unaccounted changes in blood indices.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 3","pages":"73"},"PeriodicalIF":0.0,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A giant fecaloma causing stercoral colitis secondary to aripiprazole and benztropine: A case report. 阿立哌唑和苯托品继发引起stercoral结肠炎的巨大粪瘤1例。
Q3 Medicine Pub Date : 2025-07-05 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.58
Shahem Abbarh, Mhd Kutaiba Albuni, Misbah Irshad, Adnan Humam Hajjar, Bisher Sawaf, Khalid Al-Ejji

Background: Fecaloma is a mass of hardened feces impacted in the rectum and sigmoid. When the colonic mucosal wall and vasculature are compressed, stercoral colitis, a rare type of inflammatory colitis, may occur. Despite being connected to psychiatric patients and antipsychotic medications in the literature, fecaloma remains a significant, yet often overlooked, cause of morbidity and mortality in this population.

Case presentation: A 43-year-old patient with schizophrenia being treated with aripiprazole and benztropine lost follow-up and eventually presented to the emergency department with a giant fecaloma and associated stercoral colitis. She was managed with oral and rectal laxatives and supportive therapy. Additionally, aripiprazole was discontinued.

Discussion: Antipsychotics have been associated with constipation, fecaloma, and stercoral colitis due to their anticholinergic properties. Benztropine, an antimuscarinic drug commonly used in psychiatric patients to alleviate extrapyramidal symptoms, may further decrease gastrointestinal mobility. Fecaloma and associated stercoral colitis are often diagnosed via imaging, typically a computed tomography scan of the abdomen. Management depends on the severity and generally ranges from conservative treatment to surgical options.

Conclusion: This case describes a schizophrenic patient undergoing treatment with aripiprazole and benztropine who presented with constipation and was diagnosed with a giant fecaloma complicated by stercoral colitis. The patient was managed successfully with aggressive laxatives and discontinuation of aripiprazole. Early recognition and prompt management of fecaloma are essential to mitigate associated complications. In addition, it is important to recognize risk factors for constipation and regularly review home medications, such as antipsychotics, that may cause constipation as a side effect.

背景:粪瘤是一种发生在直肠和乙状结肠内的硬粪便团块。当结肠粘膜壁和血管受压时,可发生一种罕见的炎症性结肠炎。尽管在文献中与精神病患者和抗精神病药物有关,但粪瘤仍然是这一人群中发病率和死亡率的重要原因,但往往被忽视。病例介绍:一名43岁的精神分裂症患者接受阿立哌唑和苯托品治疗,失去了随访,最终因巨大粪瘤和相关的stercoral结肠炎就诊于急诊科。给予口服和直肠泻药及支持治疗。此外,停用阿立哌唑。讨论:由于抗胆碱能的特性,抗精神病药物与便秘、粪瘤和结肠炎有关。苯托品是一种抗蛇毒碱药物,常用于精神病患者缓解锥体外系症状,可能进一步降低胃肠蠕动。粪状瘤和相关的后珊瑚结肠炎通常通过影像学诊断,通常是腹部的计算机断层扫描。治疗取决于严重程度,通常从保守治疗到手术选择。结论:本病例描述了一位接受阿立哌唑和苯托品治疗的精神分裂症患者,其表现为便秘,并被诊断为巨大粪瘤并发stercoral结肠炎。患者通过强力泻药和停用阿立哌唑治疗成功。早期识别和及时处理粪瘤对于减轻相关并发症至关重要。此外,重要的是要认识到便秘的危险因素,并定期检查可能导致便秘的家庭药物,如抗精神病药物。
{"title":"A giant fecaloma causing stercoral colitis secondary to aripiprazole and benztropine: A case report.","authors":"Shahem Abbarh, Mhd Kutaiba Albuni, Misbah Irshad, Adnan Humam Hajjar, Bisher Sawaf, Khalid Al-Ejji","doi":"10.5339/qmj.2025.58","DOIUrl":"10.5339/qmj.2025.58","url":null,"abstract":"<p><strong>Background: </strong>Fecaloma is a mass of hardened feces impacted in the rectum and sigmoid. When the colonic mucosal wall and vasculature are compressed, stercoral colitis, a rare type of inflammatory colitis, may occur. Despite being connected to psychiatric patients and antipsychotic medications in the literature, fecaloma remains a significant, yet often overlooked, cause of morbidity and mortality in this population.</p><p><strong>Case presentation: </strong>A 43-year-old patient with schizophrenia being treated with aripiprazole and benztropine lost follow-up and eventually presented to the emergency department with a giant fecaloma and associated stercoral colitis. She was managed with oral and rectal laxatives and supportive therapy. Additionally, aripiprazole was discontinued.</p><p><strong>Discussion: </strong>Antipsychotics have been associated with constipation, fecaloma, and stercoral colitis due to their anticholinergic properties. Benztropine, an antimuscarinic drug commonly used in psychiatric patients to alleviate extrapyramidal symptoms, may further decrease gastrointestinal mobility. Fecaloma and associated stercoral colitis are often diagnosed via imaging, typically a computed tomography scan of the abdomen. Management depends on the severity and generally ranges from conservative treatment to surgical options.</p><p><strong>Conclusion: </strong>This case describes a schizophrenic patient undergoing treatment with aripiprazole and benztropine who presented with constipation and was diagnosed with a giant fecaloma complicated by stercoral colitis. The patient was managed successfully with aggressive laxatives and discontinuation of aripiprazole. Early recognition and prompt management of fecaloma are essential to mitigate associated complications. In addition, it is important to recognize risk factors for constipation and regularly review home medications, such as antipsychotics, that may cause constipation as a side effect.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 2","pages":"58"},"PeriodicalIF":0.0,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the effects of bempedoic acid on lipid profiles and cardiovascular risk: An umbrella review of meta-analyses. 评估苯甲醚酸对血脂和心血管风险的影响:荟萃分析综述。
Q3 Medicine Pub Date : 2025-07-05 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.51
Ashik Ali, Sameer Bhimani, Vikash Kumar Karmani, Rubaid Azhar Dhillon, Shahzeb Saeed, Arman Amir, Palak Patel, Anim Asif, Umair Abrar Baig, Sheena Shamoon, Aatkah Naseer, Owais Ali
<p><strong>Background: </strong>This umbrella review aims to synthesize evidence from previously conducted meta-analyses and review articles to assess the effects of bempedoic acid on lipid profile and cardiovascular events.</p><p><strong>Methods: </strong>While adhering to the Preferred Reporting Items for Overviews of Reviews guidelines, PubMed, Google Scholar, Web of Science, and Scopus were searched from the database inception to June 2024 to identify relevant articles. The outcomes were total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol, triglyceride (TAG), apolipoprotein B (APOB), high-sensitivity CRP (hs-CRP), major cardiovascular events (MACE), cardiovascular mortality, and myocardial infarction (MI). A corrected covered area (CCA) assessment was performed to determine overlap among reviews. Each included review was assessed for its quality and rigor via the AMSTAR-2 tool.</p><p><strong>Results: </strong>From 18,297 articles identified during the literature search, 18 meta-analyses were included. A significant overlap was noted across studies with a corrected cover area of 44.4%. Bempedoic acid's effects on cardiovascular outcomes and lipid levels have been extensively studied. For cardiovascular mortality, the evidence is mixed: Goyal et al.<sup>21</sup> reported a risk ratio (RR) of 0.81 (95% CI 0.61-1.08) suggesting a potential benefit, while other studies, such as De Filippo et al.<sup>26</sup> and Zhang et al.<sup>24</sup>, indicate no significant association. In terms of MACE, 11 reviews show a consistent trend toward reduced risk, with RRs between 0.75 and 0.88. Bempedoic acid also appears to significantly reduce the risk of MI, with RRs and odds ratios (ORs) around 0.76. Evidence on unstable angina suggests a lower risk, although some studies do not reach statistical significance. For coronary revascularization, the data show a reduced risk, with RRs ranging from 0.74 to 0.82. Studies on coronary non-revascularization also indicate a significant risk reduction with RRs and ORs of 0.41. Regarding lipid levels, bempedoic acid consistently reduces LDL cholesterol (mean differences [MDs] from -17.5% to -33.91%), total cholesterol (MDs from -12.69% to -34.41%), and non-HDL cholesterol (MDs from -12.3% to -23.27%). The effects on HDL cholesterol are less consistent (MDs from -1.29% to -5.18%), and triglyceride levels show variable results (MDs from -8.35% to +5.23%).</p><p><strong>Conclusion: </strong>Our findings show that bempedoic acid significantly reduces the risk of MACE, nonfatal MI, coronary and noncoronary revascularization, and hospitalizations for unstable angina. While results on cardiovascular mortality are mixed, suggesting a need for further study, bempedoic acid proves to be an effective treatment for improving lipid profiles and reducing cardiovascular events, especially in patients who cannot tolerate statins. It presents a valuable option f
背景:本综述旨在综合先前进行的荟萃分析和综述文章的证据,以评估苯甲醚酸对血脂和心血管事件的影响。方法:在遵循综述的首选报告项目指南的前提下,检索PubMed、b谷歌Scholar、Web of Science和Scopus从数据库建立到2024年6月的相关文章。结果为总胆固醇、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、非高密度脂蛋白胆固醇、甘油三酯(TAG)、载脂蛋白B (APOB)、高敏CRP (hs-CRP)、主要心血管事件(MACE)、心血管死亡率和心肌梗死(MI)。进行了校正的覆盖面积(CCA)评估,以确定审查之间的重叠。通过AMSTAR-2工具评估每个纳入的审查的质量和严谨性。结果:从文献检索中确定的18297篇文章中,纳入了18篇荟萃分析。校正后的覆盖面积为44.4%。苯二甲酸对心血管结局和脂质水平的影响已被广泛研究。对于心血管疾病死亡率,证据是混合的:Goyal等人21报道的风险比(RR)为0.81 (95% CI 0.61-1.08)表明潜在的益处,而其他研究,如De Filippo等人26和Zhang等人24则表明没有显著的关联。在MACE方面,11篇综述显示风险降低的趋势一致,rr在0.75 - 0.88之间。苯甲多酸似乎也能显著降低心肌梗死的风险,rr和优势比(or)约为0.76。不稳定型心绞痛的证据表明风险较低,尽管一些研究没有达到统计学意义。对于冠状动脉血运重建术,数据显示风险降低,rr范围为0.74至0.82。对冠状动脉非血运重建术的研究也表明风险显著降低,rr和or为0.41。在脂质水平方面,苯二甲酸持续降低低密度脂蛋白胆固醇(平均差异[MDs]从-17.5%到-33.91%)、总胆固醇(MDs从-12.69%到-34.41%)和非高密度脂蛋白胆固醇(MDs从-12.3%到-23.27%)。对高密度脂蛋白胆固醇的影响不太一致(MDs从-1.29%到-5.18%),甘油三酯水平显示不同的结果(MDs从-8.35%到+5.23%)。结论:我们的研究结果表明,苯戊酸可显著降低MACE、非致死性心肌梗死、冠状动脉和非冠状动脉血运重建术以及不稳定型心绞痛住院的风险。虽然心血管死亡率的结果好坏参半,表明需要进一步的研究,但戊二甲酸被证明是改善血脂和减少心血管事件的有效治疗方法,特别是对不能耐受他汀类药物的患者。它为心血管风险管理提供了一个有价值的选择,潜在地提高了患者的预后和生活质量。需要进一步的研究来评估其长期效益和更广泛的适用性。
{"title":"Evaluating the effects of bempedoic acid on lipid profiles and cardiovascular risk: An umbrella review of meta-analyses.","authors":"Ashik Ali, Sameer Bhimani, Vikash Kumar Karmani, Rubaid Azhar Dhillon, Shahzeb Saeed, Arman Amir, Palak Patel, Anim Asif, Umair Abrar Baig, Sheena Shamoon, Aatkah Naseer, Owais Ali","doi":"10.5339/qmj.2025.51","DOIUrl":"10.5339/qmj.2025.51","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;This umbrella review aims to synthesize evidence from previously conducted meta-analyses and review articles to assess the effects of bempedoic acid on lipid profile and cardiovascular events.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;While adhering to the Preferred Reporting Items for Overviews of Reviews guidelines, PubMed, Google Scholar, Web of Science, and Scopus were searched from the database inception to June 2024 to identify relevant articles. The outcomes were total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol, triglyceride (TAG), apolipoprotein B (APOB), high-sensitivity CRP (hs-CRP), major cardiovascular events (MACE), cardiovascular mortality, and myocardial infarction (MI). A corrected covered area (CCA) assessment was performed to determine overlap among reviews. Each included review was assessed for its quality and rigor via the AMSTAR-2 tool.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;From 18,297 articles identified during the literature search, 18 meta-analyses were included. A significant overlap was noted across studies with a corrected cover area of 44.4%. Bempedoic acid's effects on cardiovascular outcomes and lipid levels have been extensively studied. For cardiovascular mortality, the evidence is mixed: Goyal et al.&lt;sup&gt;21&lt;/sup&gt; reported a risk ratio (RR) of 0.81 (95% CI 0.61-1.08) suggesting a potential benefit, while other studies, such as De Filippo et al.&lt;sup&gt;26&lt;/sup&gt; and Zhang et al.&lt;sup&gt;24&lt;/sup&gt;, indicate no significant association. In terms of MACE, 11 reviews show a consistent trend toward reduced risk, with RRs between 0.75 and 0.88. Bempedoic acid also appears to significantly reduce the risk of MI, with RRs and odds ratios (ORs) around 0.76. Evidence on unstable angina suggests a lower risk, although some studies do not reach statistical significance. For coronary revascularization, the data show a reduced risk, with RRs ranging from 0.74 to 0.82. Studies on coronary non-revascularization also indicate a significant risk reduction with RRs and ORs of 0.41. Regarding lipid levels, bempedoic acid consistently reduces LDL cholesterol (mean differences [MDs] from -17.5% to -33.91%), total cholesterol (MDs from -12.69% to -34.41%), and non-HDL cholesterol (MDs from -12.3% to -23.27%). The effects on HDL cholesterol are less consistent (MDs from -1.29% to -5.18%), and triglyceride levels show variable results (MDs from -8.35% to +5.23%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our findings show that bempedoic acid significantly reduces the risk of MACE, nonfatal MI, coronary and noncoronary revascularization, and hospitalizations for unstable angina. While results on cardiovascular mortality are mixed, suggesting a need for further study, bempedoic acid proves to be an effective treatment for improving lipid profiles and reducing cardiovascular events, especially in patients who cannot tolerate statins. It presents a valuable option f","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 2","pages":"51"},"PeriodicalIF":0.0,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pilot study on the pattern of COVID-19 information sources and its associated factors among the public in Qatar: a cross-sectional survey. 卡塔尔公众中COVID-19信息来源模式及其相关因素的试点研究:横断面调查
Q3 Medicine Pub Date : 2025-07-05 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.47
Wafa Mohammed Ahmed, Ayman Aldahshan, Mohamed Abdien, Iheb Buogmiza

Background: During the coronavirus pandemic, many people looked for information on COVID-19 through social, official, and traditional media sources. This caustic situation resulted in panic among the public, leading to many false news, conspiracy theories, and magical cures being spread among the public at an alarming rate. Controversial theories about the validity of vaccination and non-adoption of disease control resulted in a slow disease control rate and adverse impacts on global health and the economy. Recent studies have shown that health information could safely guard mental health during the COVID-19 pandemic. To adopt a disease control strategy, it is essential to identify the public confidence in information sources and the most efficient media to disseminate intervention messages to the public. The main objectives of this study were to identify from 12 alternative information sources the most utilized COVID-19 source of information, the most trusted information source, and the factors associated with high trust in a given source.

Methods: A cross-sectional online survey with 442 participants aged 18 years and above was conducted to assess public views and preferences on sources of information for COVID-19. Data was analyzed using descriptive statistics, correlation, and logistic regression analyses. Bloom's scale, composite score preference, and chi-squared test were determined for result evaluation purposes.

Results and conclusion: The study findings suggest that the Ministry of Public Health is a widely trusted information source that offers a potentially effective tool for shaping, designing, and disseminating information messages to shape public attitudes toward control of COVID-19 and enhancement of preventive actions. By offering insight into the pattern of COVID-19 information sources and its associated factors among the public in Qatar, the study formulated a set of recommendations for health decision-makers to set packages to help manage and control the spread of coronavirus.

背景:在冠状病毒大流行期间,许多人通过社交、官方和传统媒体渠道寻找有关COVID-19的信息。这种刻薄的情况引起了公众的恐慌,导致许多假新闻、阴谋论和神奇的治疗方法以惊人的速度在公众中传播。关于疫苗接种有效性的有争议的理论和不采用疾病控制导致疾病控制率缓慢,并对全球健康和经济产生不利影响。最近的研究表明,在COVID-19大流行期间,健康信息可以安全地保护心理健康。为了采取一项疾病控制战略,必须确定公众对信息来源和向公众传播干预信息的最有效媒体的信心。本研究的主要目标是从12个替代信息来源中确定使用率最高的COVID-19信息来源、最受信任的信息来源以及与给定来源的高度信任相关的因素。方法:对442名18岁及以上的参与者进行横断面在线调查,评估公众对COVID-19信息来源的看法和偏好。数据分析采用描述性统计、相关性和逻辑回归分析。采用Bloom量表、综合评分偏好、卡方检验进行结果评价。结果和结论:研究结果表明,公共卫生部是一个广泛信任的信息来源,为塑造、设计和传播信息信息提供了潜在的有效工具,以塑造公众对控制COVID-19和加强预防行动的态度。通过深入了解卡塔尔公众中COVID-19信息来源的模式及其相关因素,该研究为卫生决策者制定一揽子方案以帮助管理和控制冠状病毒的传播制定了一套建议。
{"title":"A pilot study on the pattern of COVID-19 information sources and its associated factors among the public in Qatar: a cross-sectional survey.","authors":"Wafa Mohammed Ahmed, Ayman Aldahshan, Mohamed Abdien, Iheb Buogmiza","doi":"10.5339/qmj.2025.47","DOIUrl":"10.5339/qmj.2025.47","url":null,"abstract":"<p><strong>Background: </strong>During the coronavirus pandemic, many people looked for information on COVID-19 through social, official, and traditional media sources. This caustic situation resulted in panic among the public, leading to many false news, conspiracy theories, and magical cures being spread among the public at an alarming rate. Controversial theories about the validity of vaccination and non-adoption of disease control resulted in a slow disease control rate and adverse impacts on global health and the economy. Recent studies have shown that health information could safely guard mental health during the COVID-19 pandemic. To adopt a disease control strategy, it is essential to identify the public confidence in information sources and the most efficient media to disseminate intervention messages to the public. The main objectives of this study were to identify from 12 alternative information sources the most utilized COVID-19 source of information, the most trusted information source, and the factors associated with high trust in a given source.</p><p><strong>Methods: </strong>A cross-sectional online survey with 442 participants aged 18 years and above was conducted to assess public views and preferences on sources of information for COVID-19. Data was analyzed using descriptive statistics, correlation, and logistic regression analyses. Bloom's scale, composite score preference, and chi-squared test were determined for result evaluation purposes.</p><p><strong>Results and conclusion: </strong>The study findings suggest that the Ministry of Public Health is a widely trusted information source that offers a potentially effective tool for shaping, designing, and disseminating information messages to shape public attitudes toward control of COVID-19 and enhancement of preventive actions. By offering insight into the pattern of COVID-19 information sources and its associated factors among the public in Qatar, the study formulated a set of recommendations for health decision-makers to set packages to help manage and control the spread of coronavirus.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 2","pages":"47"},"PeriodicalIF":0.0,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12337779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The patients awareness and medication adherence among high-risk stroke patients admitted in a tertiary level hospital in Qatar: A cross-sectional study. 卡塔尔某三级医院收治的高危脑卒中患者的认知和药物依从性:一项横断面研究
Q3 Medicine Pub Date : 2025-07-05 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.49
Nesiya Hassan, Bejoy Varghese, Annamma Jose, Emad Salem Ajlouni, Nisha George, Pacifico Jr Gamarcha Gellego, Rida Moh'd Odeh A M Al-Balawi, Rajvir Singh

Introduction: The burden of stroke is increasing in Qatar, similar to many other countries in the world. The prevalence of stroke risk factors plays an important role in the burden of stroke in Qatar.

Objective: This study aims to assess the stroke knowledge, recognition, prevention, and medication adherence among high-risk patients.

Methods: This was a cross-sectional study involving high-risk patients admitted to the inpatient medical unit through a paper-based survey using four adopted scales Stroke knowledge test, Stroke Recognition Questionnaire, stroke prevention awareness, and Medication Adherence Rating Scale tool. Two hundred ninety-nine completed responses from the participants were used for analysis.

Results: The 41-50-year-old age group was most represented (33.11%) with a median age of 49 years. The male-female ratio was approximately 3:1 and 30.10% of the participants held a graduate degree or higher.The majority of the patients (41.47%) are obese (BMI > 30) and overweight (31.10%). The mean stroke knowledge was 38.01 ± 15.78, while the recognition and prevention domains had mean scores of 67.85 ± 10.85 and 77.55 ± 27.63 respectively. The medication adherence group has a statistically significant association with stroke recognition and prevention domains with a mean score of 72.14 ± 12.34 (p = 0.000) and 88.87 ± 24.75 (p = 0.000) respectively.

Conclusion: Participants' awareness regarding stroke knowledge was low compared to recognition and preventive measures. Stroke awareness positively correlates with medication adherence among high-risk patients admitted to the inpatient unit.

与世界上许多其他国家类似,卡塔尔的中风负担正在增加。卒中危险因素的流行在卡塔尔卒中负担中起着重要作用。目的:探讨高危患者脑卒中知识、认知、预防及药物依从性。方法:采用采用脑卒中知识测试、脑卒中认知问卷、脑卒中预防意识和药物依从性评定量表工具的四种量表,对住院医疗单元的高危患者进行横断面调查。来自参与者的299份完整回复被用于分析。结果:以41 ~ 50岁年龄组最多(33.11%),中位年龄49岁。男女比例约为3:1,30.10%的参与者拥有研究生或更高学位。多数患者(41.47%)为肥胖(BMI为bb30)和超重(31.10%)。卒中知识平均得分为38.01±15.78分,卒中认知和预防知识平均得分分别为67.85±10.85分和77.55±27.63分。服药依从组与脑卒中识别和预防领域的平均评分分别为72.14±12.34分(p = 0.000)和88.87±24.75分(p = 0.000),具有统计学意义。结论:与认知和预防措施相比,参与者对脑卒中知识的认知度较低。卒中意识与住院高危患者的药物依从性呈正相关。
{"title":"The patients awareness and medication adherence among high-risk stroke patients admitted in a tertiary level hospital in Qatar: A cross-sectional study.","authors":"Nesiya Hassan, Bejoy Varghese, Annamma Jose, Emad Salem Ajlouni, Nisha George, Pacifico Jr Gamarcha Gellego, Rida Moh'd Odeh A M Al-Balawi, Rajvir Singh","doi":"10.5339/qmj.2025.49","DOIUrl":"10.5339/qmj.2025.49","url":null,"abstract":"<p><strong>Introduction: </strong>The burden of stroke is increasing in Qatar, similar to many other countries in the world. The prevalence of stroke risk factors plays an important role in the burden of stroke in Qatar.</p><p><strong>Objective: </strong>This study aims to assess the stroke knowledge, recognition, prevention, and medication adherence among high-risk patients.</p><p><strong>Methods: </strong>This was a cross-sectional study involving high-risk patients admitted to the inpatient medical unit through a paper-based survey using four adopted scales Stroke knowledge test, Stroke Recognition Questionnaire, stroke prevention awareness, and Medication Adherence Rating Scale tool. Two hundred ninety-nine completed responses from the participants were used for analysis.</p><p><strong>Results: </strong>The 41-50-year-old age group was most represented (33.11%) with a median age of 49 years. The male-female ratio was approximately 3:1 and 30.10% of the participants held a graduate degree or higher.The majority of the patients (41.47%) are obese (BMI > 30) and overweight (31.10%). The mean stroke knowledge was 38.01 ± 15.78, while the recognition and prevention domains had mean scores of 67.85 ± 10.85 and 77.55 ± 27.63 respectively. The medication adherence group has a statistically significant association with stroke recognition and prevention domains with a mean score of 72.14 ± 12.34 (<i>p</i> = 0.000) and 88.87 ± 24.75 (<i>p</i> = 0.000) respectively.</p><p><strong>Conclusion: </strong>Participants' awareness regarding stroke knowledge was low compared to recognition and preventive measures. Stroke awareness positively correlates with medication adherence among high-risk patients admitted to the inpatient unit.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 2","pages":"49"},"PeriodicalIF":0.0,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12337777/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing the use of sodium-glucose cotransporter-2 inhibitors in type-2 diabetic patients with chronic kidney disease, through a key performance indicator program. 通过关键绩效指标项目,加强钠-葡萄糖共转运蛋白-2抑制剂在2型糖尿病合并慢性肾病患者中的应用
Q3 Medicine Pub Date : 2025-06-30 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.50
Muhammad Asim, Ramzi Abdul Rahiman, Muhammad Abdul Azim Baig, Hassan Al-Malki

Background: Despite substantial clinical evidence and recommendations from international societies supporting the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for managing patients with type-2 diabetes (T2D) and chronic kidney disease (CKD), their adoption has remained limited. To address this, the nephrology quality improvement (QI) team at Hamad Medical Corporation (HMC), Qatar, implemented a key performance indicator (KPI) program in March 2022, aiming to ensure that at least 80% of eligible T2D-CKD patients at HMC were receiving SGLT2i by December 31, 2023.

Methods: The use of SGLT2i and angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) in T2D-CKD patients attending nephrology clinics at HMC hospitals were assessed through retrospective surveys using a cluster-based sampling approach. Nephrology physicians were then updated on the results of these retrospective surveys as well as evidence from the SGLT2i trial and guidelines. The aims, objectives, and targets of the KPI program were clearly defined. Three additional surveys were conducted at 6-month intervals. A multifaceted QI intervention approach-combining audit, feedback, leadership engagement, and peer consultation-was implemented to drive improvement.

Results: Retrospective surveys conducted in November 2021 and February 2022 revealed that 38% and 44% of eligible T2D-CKD patients were receiving SGLT2i therapy, compared to 98% and 99% for ACEi/ARB. Four months after implementing the KPI program, the July 2022 survey revealed no change in SGLT2i use (41%), while ACEi/ARB prescription rates remained near 100%. Following QI interventions in November 2022, the February 2023 survey revealed a significant increase in SGLT2i use, rising to 88%, with SGLT2i initiation in naive patients increasing from 34% to 61%. The final survey conducted in August 2023 showed that 84% of patients were receiving SGLT2i therapy.

Conclusion: Our KPI program boosted SGLT2i prescription rates for eligible T2D-CKD patients in nephrology clinics, resulting in a 47% rise from 41% to 88%. It overcame prescription inertia and accelerated the guideline adoption by combining real-time feedback, leadership engagement, and peer discussions. The sharp rise in new prescriptions following November 2022 feedback underscores its direct influence on behavior modification rather than a broader trend.

背景:尽管有大量的临床证据和国际社会的建议支持使用钠-葡萄糖共转运蛋白-2抑制剂(SGLT2i)来治疗2型糖尿病(T2D)和慢性肾脏疾病(CKD)患者,但它们的采用仍然有限。为了解决这一问题,卡塔尔哈马德医疗公司(HMC)的肾脏病质量改善(QI)团队于2022年3月实施了一项关键绩效指标(KPI)计划,旨在确保HMC至少80%符合条件的ttd - ckd患者在2023年12月31日之前接受SGLT2i治疗。方法:采用基于聚类抽样的回顾性调查方法,评估在HMC医院肾内科就诊的T2D-CKD患者中SGLT2i和血管紧张素转换酶抑制剂(ACEi)或血管紧张素II受体阻滞剂(ARB)的使用情况。肾内科医生随后更新了这些回顾性调查的结果以及SGLT2i试验和指南的证据。明确定义了KPI计划的目的、目标和目标。每隔6个月进行另外3次调查。实施了多方面的质量评价干预方法——结合审计、反馈、领导参与和同行咨询——以推动改进。结果:在2021年11月和2022年2月进行的回顾性调查显示,38%和44%的符合条件的T2D-CKD患者接受了SGLT2i治疗,而ACEi/ARB的这一比例分别为98%和99%。在实施KPI项目四个月后,2022年7月的调查显示SGLT2i的使用没有变化(41%),而ACEi/ARB处方率仍然接近100%。在2022年11月QI干预之后,2023年2月的调查显示SGLT2i的使用显著增加,上升到88%,初始患者的SGLT2i起始率从34%增加到61%。2023年8月进行的最终调查显示,84%的患者正在接受SGLT2i治疗。结论:我们的KPI项目提高了肾内科诊所符合条件的T2D-CKD患者的SGLT2i处方率,使SGLT2i从41%上升到88%,上升了47%。它克服了处方惯性,并通过结合实时反馈、领导参与和同行讨论加速了指导方针的采用。在2022年11月的反馈之后,新处方的急剧增加凸显了其对行为矫正的直接影响,而不是更广泛的趋势。
{"title":"Enhancing the use of sodium-glucose cotransporter-2 inhibitors in type-2 diabetic patients with chronic kidney disease, through a key performance indicator program.","authors":"Muhammad Asim, Ramzi Abdul Rahiman, Muhammad Abdul Azim Baig, Hassan Al-Malki","doi":"10.5339/qmj.2025.50","DOIUrl":"10.5339/qmj.2025.50","url":null,"abstract":"<p><strong>Background: </strong>Despite substantial clinical evidence and recommendations from international societies supporting the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for managing patients with type-2 diabetes (T2D) and chronic kidney disease (CKD), their adoption has remained limited. To address this, the nephrology quality improvement (QI) team at Hamad Medical Corporation (HMC), Qatar, implemented a key performance indicator (KPI) program in March 2022, aiming to ensure that at least 80% of eligible T2D-CKD patients at HMC were receiving SGLT2i by December 31, 2023.</p><p><strong>Methods: </strong>The use of SGLT2i and angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) in T2D-CKD patients attending nephrology clinics at HMC hospitals were assessed through retrospective surveys using a cluster-based sampling approach. Nephrology physicians were then updated on the results of these retrospective surveys as well as evidence from the SGLT2i trial and guidelines. The aims, objectives, and targets of the KPI program were clearly defined. Three additional surveys were conducted at 6-month intervals. A multifaceted QI intervention approach-combining audit, feedback, leadership engagement, and peer consultation-was implemented to drive improvement.</p><p><strong>Results: </strong>Retrospective surveys conducted in November 2021 and February 2022 revealed that 38% and 44% of eligible T2D-CKD patients were receiving SGLT2i therapy, compared to 98% and 99% for ACEi/ARB. Four months after implementing the KPI program, the July 2022 survey revealed no change in SGLT2i use (41%), while ACEi/ARB prescription rates remained near 100%. Following QI interventions in November 2022, the February 2023 survey revealed a significant increase in SGLT2i use, rising to 88%, with SGLT2i initiation in naive patients increasing from 34% to 61%. The final survey conducted in August 2023 showed that 84% of patients were receiving SGLT2i therapy.</p><p><strong>Conclusion: </strong>Our KPI program boosted SGLT2i prescription rates for eligible T2D-CKD patients in nephrology clinics, resulting in a 47% rise from 41% to 88%. It overcame prescription inertia and accelerated the guideline adoption by combining real-time feedback, leadership engagement, and peer discussions. The sharp rise in new prescriptions following November 2022 feedback underscores its direct influence on behavior modification rather than a broader trend.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 2","pages":"50"},"PeriodicalIF":0.0,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338110/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of epithelial-mesenchymal markers in predicting metastasis of papillary thyroid carcinoma: A retrospective case-control study. 上皮-间充质标志物在预测甲状腺乳头状癌转移中的作用:回顾性病例对照研究。
Q3 Medicine Pub Date : 2025-06-30 eCollection Date: 2025-01-01 DOI: 10.5339/qmj.2025.45
Iqbal Amer, Esraa Aldujaily, Ali Alfatlawi

Background: Papillary thyroid carcinoma (PTC) accounts for 90% of thyroid malignancies, with lymph node metastasis being a critical prognostic factor. However, the mechanisms driving metastasis remain unclear. This study investigated the role of E-cadherin and zinc finger E-box-binding homeobox 1 in cancer progression among Iraqi PTC patients.

Methods: The expression levels of E-cadherin and zinc finger E-box-binding homeobox 1 were analyzed in 50 Iraqi patients diagnosed with PTC without lymph node metastases, evaluated between January 2015 and December 2021. The Pearson correlation coefficient between these markers and the risk of lymph node metastasis, as well as their relationship to tumor grade and stage, was calculated. The area under the receiver operating characteristic (ROC) curve for both markers was performed. The Medical Ethics Committee of the Iraqi Ministry of Higher Education and Scientific Research (Reference No. 14) approved the study.

Results: This study examined 50 PTC cases, revealing significant associations between E-cadherin and zinc finger E-box-binding homeobox 1 expression and lymph node metastasis, clinical stage, and tumor grade. Zinc finger E-box-binding homeobox 1 expression was higher in metastatic cases (92% vs. 16%), while E-cadherin was lower (24% vs. 84%). Zinc finger E-box-binding homeobox 1 positively correlated with lymph node metastasis (r = 0.68), stage (r = 0.72), and grade (r = 0.56), whereas E-cadherin showed negative correlations (r = -0.60, -0.59, and -0.52, respectively). ROC analysis showed areas under the curve of 0.88 zinc finger E-box-binding homeobox 1 and 0.82 (E-cadherin), suggesting their potential as biomarkers for metastasis prediction.

Conclusions: The study concluded that E-cadherin and zinc finger E-box-binding homeobox 1 are key predictors of lymph node metastasis, tumor grade, and stage in PTC. Monitoring these markers could enhance clinical decision-making and patient management.

背景:甲状腺乳头状癌(PTC)占甲状腺恶性肿瘤的90%,淋巴结转移是一个关键的预后因素。然而,驱动转移的机制仍不清楚。本研究探讨了E-cadherin和锌指E-box-binding homeobox 1在伊拉克PTC患者癌症进展中的作用。方法:对2015年1月至2021年12月诊断为PTC且无淋巴结转移的50例伊拉克患者进行E-cadherin和锌指E-box-binding homeobox 1的表达水平进行分析。计算这些标志物与淋巴结转移风险之间的Pearson相关系数,以及它们与肿瘤分级和分期的关系。测量两种指标的受试者工作特征(ROC)曲线下面积。伊拉克高等教育和科学研究部医学伦理委员会(参考文献第14号)批准了这项研究。结果:本研究检查了50例PTC病例,揭示了E-cadherin和锌指E-box-binding homeobox 1表达与淋巴结转移、临床分期和肿瘤分级之间的显著相关性。锌指E-box-binding homeobox - 1在转移病例中的表达较高(92%比16%),而E-cadherin的表达较低(24%比84%)。锌指E-box-binding homeobox 1与淋巴结转移(r = 0.68)、分期(r = 0.72)、分级(r = 0.56)呈正相关,而E-cadherin呈负相关(r分别为-0.60、-0.59、-0.52)。ROC分析显示,锌指E-box-binding homeobox 1曲线下面积为0.88,E-cadherin曲线下面积为0.82,提示它们有可能作为转移预测的生物标志物。结论:E-cadherin和锌指E-box-binding homeobox 1是PTC淋巴结转移、肿瘤分级和分期的关键预测因子。监测这些标志物可以提高临床决策和患者管理。
{"title":"Role of epithelial-mesenchymal markers in predicting metastasis of papillary thyroid carcinoma: A retrospective case-control study.","authors":"Iqbal Amer, Esraa Aldujaily, Ali Alfatlawi","doi":"10.5339/qmj.2025.45","DOIUrl":"10.5339/qmj.2025.45","url":null,"abstract":"<p><strong>Background: </strong>Papillary thyroid carcinoma (PTC) accounts for 90% of thyroid malignancies, with lymph node metastasis being a critical prognostic factor. However, the mechanisms driving metastasis remain unclear. This study investigated the role of E-cadherin and zinc finger E-box-binding homeobox 1 in cancer progression among Iraqi PTC patients.</p><p><strong>Methods: </strong>The expression levels of E-cadherin and zinc finger E-box-binding homeobox 1 were analyzed in 50 Iraqi patients diagnosed with PTC without lymph node metastases, evaluated between January 2015 and December 2021. The Pearson correlation coefficient between these markers and the risk of lymph node metastasis, as well as their relationship to tumor grade and stage, was calculated. The area under the receiver operating characteristic (ROC) curve for both markers was performed. The Medical Ethics Committee of the Iraqi Ministry of Higher Education and Scientific Research (Reference No. 14) approved the study.</p><p><strong>Results: </strong>This study examined 50 PTC cases, revealing significant associations between E-cadherin and zinc finger E-box-binding homeobox 1 expression and lymph node metastasis, clinical stage, and tumor grade. Zinc finger E-box-binding homeobox 1 expression was higher in metastatic cases (92% vs. 16%), while E-cadherin was lower (24% vs. 84%). Zinc finger E-box-binding homeobox 1 positively correlated with lymph node metastasis (<i>r</i> = 0.68), stage (<i>r</i> = 0.72), and grade (<i>r</i> = 0.56), whereas E-cadherin showed negative correlations (<i>r</i> = -0.60, -0.59, and -0.52, respectively). ROC analysis showed areas under the curve of 0.88 zinc finger E-box-binding homeobox 1 and 0.82 (E-cadherin), suggesting their potential as biomarkers for metastasis prediction.</p><p><strong>Conclusions: </strong>The study concluded that E-cadherin and zinc finger E-box-binding homeobox 1 are key predictors of lymph node metastasis, tumor grade, and stage in PTC. Monitoring these markers could enhance clinical decision-making and patient management.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2025 2","pages":"45"},"PeriodicalIF":0.0,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12332897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Qatar Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1